Genxi Biotech's US stock market surged by over 70% before trading
我放心你带套猛
发表于 2023-12-26 18:19:09
293
0
0
On December 26th, the US stock market of Genxi Biotechnology surged by over 70% before the market, and AstraZeneca acquired Genxi Biotechnology for $1.2 billion.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- US chip stocks continue to rise, TSMC gains over 8%
- Bilibili's US stock market rose more than 4% before trading
- Chinese concept stocks and US stocks generally rose before the market opened, with Bilibili rising nearly 4%
- Chinese concept stocks and US stocks generally strengthened before the market opened, and Futu Holdings rose more than 5%
- Bank of America survey: US stock market expected to be the best asset of 2025 after Trump's victory!
- Chinese concept stocks and US stocks mostly rose before the market, with extreme discounts and a nearly 6% increase
- Most US bank stocks rise, with JPMorgan Chase exceeding 1%
- Fuguo Bank's US stock market rose nearly 3% before trading
- RBC Capital raises target prices for multiple US bank stocks
- Micron Technology's US stock fell more than 14% in pre-market trading